MAV Beauty Brands Inc (MAV.CA) Stock Fundamental Analysis
TSX:MAV - Toronto Stock Exchange - CA57767U1066 - Common Stock - Currency: CAD
Overall MAV gets a fundamental rating of 4 out of 10. We evaluated MAV against 5 industry peers in the Personal Care Products industry. While MAV seems to be doing ok healthwise, there are quite some concerns on its profitability. MAV has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
MAV had negative earnings in the past year.
In the past year MAV had a positive cash flow from operations.
In multiple years MAV reported negative net income over the last 5 years.
Of the past 5 years MAV 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -140.13%, MAV is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
MAV's Return On Invested Capital of 1.36% is fine compared to the rest of the industry. MAV outperforms 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MAV is below the industry average of 7.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -140.13% | ||
| ROE | N/A | ||
| ROIC | 1.36% |
ROA(3y)-52.02%
ROA(5y)-31.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.21%
ROIC(5y)2.83%
1.3 Margins
MAV has a better Operating Margin (2.22%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of MAV has declined.
MAV has a better Gross Margin (42.29%) than 66.67% of its industry peers.
MAV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.22% | ||
| PM (TTM) | N/A | ||
| GM | 42.29% |
OM growth 3Y-30.51%
OM growth 5Y-26.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.85%
GM growth 5Y-6.66%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAV is destroying value.
The number of shares outstanding for MAV has been increased compared to 1 year ago.
The debt/assets ratio for MAV is higher compared to a year ago.
2.2 Solvency
MAV has an Altman-Z score of -2.02. This is a bad value and indicates that MAV is not financially healthy and even has some risk of bankruptcy.
MAV's Altman-Z score of -2.02 is fine compared to the rest of the industry. MAV outperforms 66.67% of its industry peers.
The Debt to FCF ratio of MAV is 26.35, which is on the high side as it means it would take MAV, 26.35 years of fcf income to pay off all of its debts.
MAV's Debt to FCF ratio of 26.35 is fine compared to the rest of the industry. MAV outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 26.35 | ||
| Altman-Z | -2.02 |
ROIC/WACC0.35
WACC3.84%
2.3 Liquidity
A Current Ratio of 3.06 indicates that MAV has no problem at all paying its short term obligations.
MAV's Current ratio of 3.06 is fine compared to the rest of the industry. MAV outperforms 66.67% of its industry peers.
A Quick Ratio of 1.50 indicates that MAV should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.50, MAV is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.06 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
MAV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -261.11%.
The Revenue for MAV has decreased by -11.74% in the past year. This is quite bad
MAV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.42% yearly.
EPS 1Y (TTM)-261.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.49%
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y-5.8%
Revenue growth 5Y16.42%
Sales Q2Q%-18.53%
3.2 Future
MAV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.24% yearly.
Based on estimates for the next years, MAV will show a decrease in Revenue. The Revenue will decrease by -3.87% on average per year.
EPS Next Y58.21%
EPS Next 2Y53.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.8%
Revenue Next 2Y-3.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MAV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MAV is valuated cheaply with a Price/Forward Earnings ratio of 0.58.
Based on the Price/Forward Earnings ratio, MAV is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
MAV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.58 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAV indicates a somewhat cheap valuation: MAV is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MAV is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.23 | ||
| EV/EBITDA | 21.1 |
4.3 Compensation for Growth
MAV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MAV's earnings are expected to grow with 53.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.24%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for MAV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MAV (11/13/2023, 7:00:00 PM)
0.04
+0 (+14.29%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners12.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.48M
Analysts45.71
Price Target0.41 (925%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-65.02%
Min EPS beat(2)-65.02%
Max EPS beat(2)-65.02%
EPS beat(4)0
Avg EPS beat(4)-214.85%
Min EPS beat(4)-471.29%
Max EPS beat(4)-65.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)1.82%
Revenue beat(4)1
Avg Revenue beat(4)-6.37%
Min Revenue beat(4)-14.06%
Max Revenue beat(4)1.82%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.58 | ||
| P/S | 0.01 | ||
| P/FCF | 0.23 | ||
| P/OCF | 0.22 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.1 |
EPS(TTM)-0.2
EYN/A
EPS(NY)0.07
Fwd EY172.73%
FCF(TTM)0.18
FCFY439.44%
OCF(TTM)0.19
OCFY463.41%
SpS3.11
BVpS-0.74
TBVpS-2.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -140.13% | ||
| ROE | N/A | ||
| ROCE | 1.89% | ||
| ROIC | 1.36% | ||
| ROICexc | 1.48% | ||
| ROICexgc | 4.43% | ||
| OM | 2.22% | ||
| PM (TTM) | N/A | ||
| GM | 42.29% | ||
| FCFM | 5.65% |
ROA(3y)-52.02%
ROA(5y)-31.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.21%
ROIC(5y)2.83%
ROICexc(3y)3.45%
ROICexc(5y)2.98%
ROICexgc(3y)18.45%
ROICexgc(5y)20.46%
ROCE(3y)4.46%
ROCE(5y)3.92%
ROICexcg growth 3Y-32.55%
ROICexcg growth 5Y-56.37%
ROICexc growth 3Y3.68%
ROICexc growth 5Y-2.69%
OM growth 3Y-30.51%
OM growth 5Y-26.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.85%
GM growth 5Y-6.66%
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 26.35 | ||
| Debt/EBITDA | 21.18 | ||
| Cap/Depr | 6.94% | ||
| Cap/Sales | 0.31% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 89.51% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.06 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | -2.02 |
F-Score4
WACC3.84%
ROIC/WACC0.35
Cap/Depr(3y)17.04%
Cap/Depr(5y)26.26%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-261.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.49%
EPS Next Y58.21%
EPS Next 2Y53.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.74%
Revenue growth 3Y-5.8%
Revenue growth 5Y16.42%
Sales Q2Q%-18.53%
Revenue Next Year-12.8%
Revenue Next 2Y-3.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-74.4%
EBIT growth 3Y-34.54%
EBIT growth 5Y-14.03%
EBIT Next Year108.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.81%
FCF growth 3Y1.29%
FCF growth 5Y26.9%
OCF growth 1Y-64.27%
OCF growth 3Y-7.19%
OCF growth 5Y24.91%